Fetal loss after amniocentesis in a series of 5,780 procedures

Fetal Diagnosis and Therapy

Volumn 23, Issue 3, 2008, Pages 217-221

  Gaudry, P ^a   Grange G ^b   Lebbar, A ^b   Choiset, A ^b   Girard, S ^b   Goffinet, F ^b   Lewin, F ^b  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b Groupe Hospitalier Cochin ^*  (France)

Author keywords

Amniocentesis; Antenatal diagnosis; Intrauterine death; Prenatal counseling

Indexed keywords

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; FEMALE; FETUS WASTAGE; GENETIC PROCEDURES; GESTATIONAL AGE; HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AMNIOCENTESIS; COHORT STUDIES; FEMALE; FETAL DEATH; FETAL MORTALITY; FRANCE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 42349095709     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116744     Document Type: Article

References (12)

1. Blondel B, Norton J, du Mazaubrun C, Breart G: Development of the main indicators of perinatal health in metropolitan France between 1995 and 1998. Results of the national perinatal survey (in French). J Gynecol Obstet Biol Reprod (Paris) 2001;30:552-564.
2. Tabor A, Philip J, Madsen M, Bang J, Obel E, Norgaard-Pedersen B: Randomised controlled trial of genetic amniocentesis in 4,606 low-risk women. Lancet 1986;i:1287-1293.
3. The Canadian Early and Mid-Trimester Amniocentesis Trial (CEMAT) Group: Randomised trial to assess safety and fetal outcome of early and midtrimester amnio centesis. Lancet 1998;351:242-247.
4. Antsaklis A, Papantoniou N, Xygakis A, Mesogitis S, Tzortzis E, Michalas S: Genetic amniocentesis in women 20-34 years old: associated risks. Prenat Diagn 2000;20:247-250.
5. Horger EO 3rd, Finch H, Vincent VA: A single physician's experience with four thousand six hundred genetic amniocenteses. Am J Obstet Gynecol 2001;185:279-288.
6. Muller F, Thibaud D, Poloce F, Gelineau MC, Bernard M, Brochet C, Millet C, Real JY, Dommergues M: Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers. Prenat Diagn 2002;22:1036-1039.
7. Saltvedt S, Almström H: Fetal loss rate after second trimester amniocentesis at different gestational age. Acta Obstet Gynecol Scand 1999;78:10-14.
8. Blackwell SC, Abundis MG, Nehra PC: Five-year experience with midtrimester amniocentesis performed by a single group of obstetricians- gynecologists at a community hospital. Am J Obstet Gynecol 2002;186:1130-1132.
9. Scott F, Peters H, Boogert T, Robertson R, Anderson J, McLennan A, Kesby G, Edelman D: The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice. Aust NZ J Obstet Gynaecol 2002;42:55-58.
10. Tongsong T, Wanapirak C, Sirivatanapa P, Piyamongkol W, Sirichotiyakul S, Yampochai A: Amniocentesis-related fetal loss: a cohort study. Obstet Gynecol 1998;92:64-67.
11. Papantoniou NE, Daskalakis GJ, Tziotis JG, Kitmirides SJ, Mesogitis SA, Antsaklis AJ: Risk factors predisposing to fetal loss following a second trimester amniocentesis. BJOG 2001;108:1053-1056.
12. Reid KP, Gurrin LC, Dickinson JE, Newnham JP, Phillips JM: Pregnancy loss rates following second trimester genetic amniocentesis. Aust NZ J Obstet Gynaecol 1999;39:281-285.